cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester structure
|
Common Name | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester | ||
---|---|---|---|---|
CAS Number | 84494-72-4 | Molecular Weight | 356.541 | |
Density | 0.9±0.1 g/cm3 | Boiling Point | 443.5±24.0 °C at 760 mmHg | |
Molecular Formula | C24H36O2 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 102.1±21.2 °C |
Use of cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl esterEthyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is enriched in the ethyl ester fraction by the selective alcoholysis of fatty acid ethyl esters originating from tuna oil with lauryl alcohol. |
Name | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate |
---|---|
Synonym | More Synonyms |
Description | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is enriched in the ethyl ester fraction by the selective alcoholysis of fatty acid ethyl esters originating from tuna oil with lauryl alcohol. |
---|---|
Related Catalog | |
In Vitro | Ethyl cis-4,7,10,13,16,19-Docosahexaenoate (Ethyl docosahexaenoate; E-DHA) is efficiently enriched by the selective alcoholysis of ethyl esters originating from tuna oil with lauryl alcohol using immobilized lipase[1]. |
References |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 443.5±24.0 °C at 760 mmHg |
Molecular Formula | C24H36O2 |
Molecular Weight | 356.541 |
Flash Point | 102.1±21.2 °C |
Exact Mass | 356.271515 |
PSA | 26.30000 |
LogP | 7.77 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.504 |
Storage condition | −20°C |
Docosahexaenoic acid counteracts attenuation of CD95-induced cell death by inorganic mercury.
Toxicol. Appl. Pharmacol. 282(1) , 61-7, (2015) In the United States the principal environmental exposure to mercury is through dietary consumption of sea food. Although the mechanism by which low levels of mercury affect the nervous system is not ... |
|
Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats.
Food Funct. 2(7) , 386-94, (2011) Deposition of amyloid β peptide (Aβ) into the brain causes cognitive impairment. We investigated whether prescription pre-administration of n-3 fatty acids improves cognitive learning ability in young... |
|
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Am. J. Hematol. 83(6) , 437-45, (2008) Newly described lipoxygenase (LOX)-generated lipid mediators, that is, resolvins and protectins as well as lipoxins, are both anti-inflammatory and proresolving. We aimed to determine whether these li... |
Ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate |
4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester, (4E,7E,10E,13E,16E,19E)- |
Ethyl (4E,7E,10E,13E,16E,19E)-4,7,10,13,16,19-docosahexaenoate |
cis-4,7,10,13,16,19-docosahexaenoic acid ethyl ester |
Ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoate |
MFCD00056293 |
4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester, (4Z,7Z,10Z,13Z,16Z,19Z)- |
4,7,10,13,16,19-docosahexaenoic acid ethyl ester |
4,7,10,13,16,19-Docosahexaenoic acid, ethyl ester |